Fortis Healthcare Limited has reported a remarkable 89.4% year-on-year (YoY) increase in net profit, reaching ₹254.3 crore for the third quarter of FY25, compared to ₹134.2 crore in Q3 FY24.
The company’s revenue from operations rose 14.8% YoY to ₹1,928.3 crore, up from ₹1,679.7 crore in the same period last year. This growth was driven by higher patient volumes, improved hospital occupancy, and continued expansion in diagnostic services.
Key Financial Highlights (Q3 FY25 vs. Q3 FY24):
- Revenue from operations: ₹1,928.3 crore (+14.8% YoY)
- Net profit: ₹254.3 crore (+89.4% YoY)
- EBITDA: ₹396.0 crore (+97.2% YoY)
- EBITDA margin: 20.5% (vs. 12.1% in Q3 FY24)
- Total income: ₹1,949.1 crore (+15.6% YoY)
- Earnings per share (EPS): ₹3.28 (vs. ₹1.78 in Q3 FY24)
Segment Performance:
- Healthcare services revenue: ₹1,622.9 crore (vs. ₹1,389.4 crore in Q3 FY24)
- Diagnostics business revenue: ₹342.2 crore (vs. ₹330.7 crore in Q3 FY24)
Growth Drivers:
- Strong growth in high-end medical procedures and elective surgeries.
- Expansion of diagnostic services under the Agilus brand.
- Implementation of operational efficiencies leading to higher EBITDA margins.
Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, commented,
“Our performance in Q3 FY25 reflects our commitment to delivering high-quality healthcare services while driving efficiency and profitability. With increased demand for advanced medical care, we continue to invest in infrastructure and expand our diagnostic capabilities. We remain optimistic about sustaining this momentum in the coming quarters.”
Fortis Healthcare aims to continue expanding its hospital network and diagnostic offerings while leveraging digital healthcare solutions to enhance patient experience.
